Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3

Biochem Biophys Res Commun. 2007 Jun 1;357(2):487-92. doi: 10.1016/j.bbrc.2007.03.160. Epub 2007 Apr 4.

Abstract

Machado-Joseph disease (MJD) is a dominant neurodegenerative disorder caused by an expansion of the polyglutamine tract in MJD-1 gene product, ataxin-3. Recently, studies show that phosphorylation of polyglutamine disease proteins, such as huntingtin, ataxin-1 and DRPLA, plays an important role in regulating pathogenesis. However, the kinase that phosphorylates ataxin-3 remains unknown. Here we show that S256 site in ataxin-3 is phosphorylated by GSK 3beta. Moreover, S256A mutant of expanded ataxin-3 forms high molecular weight protein aggregation, whereas S256D mutant and expanded ataxin-3 without mutation on this site are monomeric. The molecular chaperone Hsp70 represses the aggregation of S256A mutant. Our results imply that phosphorylation of serine 256 in ataxin-3 by GSK 3beta regulates ataxin-3 aggregation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxin-3
  • Binding Sites
  • Cell Line
  • Enzyme Activation
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Kidney / metabolism*
  • Multiprotein Complexes / metabolism
  • Nerve Tissue Proteins / metabolism*
  • Nuclear Proteins / metabolism*
  • Phosphorylation
  • Protein Binding
  • Repressor Proteins / metabolism*
  • Serine / metabolism*

Substances

  • Multiprotein Complexes
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Repressor Proteins
  • Serine
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
  • ATXN3 protein, human
  • Ataxin-3